These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9927255)

  • 1. Synthesis of peptide and pseudopeptide amides inhibiting the proliferation of small cell and epithelial types of lung carcinoma cells.
    Nyéki O; Rill A; Schon I; Orosz A; Schrett J; Bartha L; Nagy J
    J Pept Sci; 1998 Dec; 4(8):486-95. PubMed ID: 9927255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New short-chain analogs of a substance-P antagonist inhibit proliferation of human small-cell lung-cancer cells in vitro and in vivo.
    Orosz A; Schrett J; Nagy J; Bartha L; Schön I; Nyéki O
    Int J Cancer; 1995 Jan; 60(1):82-7. PubMed ID: 7529212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
    Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of potent gastrin-releasing peptide antagonists having a D-Pro-psi(CH2NH)-Phe-NH2 C terminus.
    Leban JJ; Kull FC; Landavazo A; Stockstill B; McDermed JD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1922-6. PubMed ID: 8446610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression.
    Thomas F; Arvelo F; Antoine E; Jacrot M; Poupon MF
    Cancer Res; 1992 Sep; 52(18):4872-7. PubMed ID: 1325285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conveyance of partial agonism/antagonism to bombesin/gastrin-releasing peptide analogues on Swiss 3T3 cells by a carboxyl-terminal leucine insertion.
    Kull FC; Leban JJ; Landavazo A; Stewart KD; Stockstill B; McDermed JD
    J Biol Chem; 1992 Oct; 267(29):21132-8. PubMed ID: 1400423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance P analogues function as bombesin receptor antagonists and inhibit small cell lung cancer clonal growth.
    Bepler G; Zeymer U; Mahmoud S; Fiskum G; Palaszynski E; Rotsch M; Willey J; Koros A; Cuttitta F; Moody TW
    Peptides; 1988; 9(6):1367-72. PubMed ID: 2470067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
    Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW
    Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi.
    Radulovic S; Cai RZ; Serfozo P; Groot K; Redding TW; Pinski J; Schally AV
    Int J Pept Protein Res; 1991 Dec; 38(6):593-600. PubMed ID: 1726427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small cell lung cancer bombesin receptors are antagonized by reduced peptide bond analogues.
    Mahmoud S; Palaszynski E; Fiskum G; Coy DH; Moody TW
    Life Sci; 1989; 44(5):367-73. PubMed ID: 2536883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives.
    Cai RZ; Reile H; Armatis P; Schally AV
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12664-8. PubMed ID: 7809097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity.
    Coy DH; Taylor JE; Jiang NY; Kim SH; Wang LH; Huang SC; Moreau JP; Gardner JD; Jensen RT
    J Biol Chem; 1989 Sep; 264(25):14691-7. PubMed ID: 2475489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma.
    Koppán M; Halmos G; Arencibia JM; Lamharzi N; Schally AV
    Cancer; 1998 Oct; 83(7):1335-43. PubMed ID: 9762934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
    Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N
    Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of inositol lipid hydrolysis in human breast cancer cells by two classes of bombesin antagonist.
    Patel KV; Schrey MP
    J Mol Endocrinol; 1991 Feb; 6(1):71-8. PubMed ID: 1707628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bombesin antagonists on the growth of small cell lung cancer cells in vitro.
    Layton JE; Scanlon DB; Soveny C; Morstyn G
    Cancer Res; 1988 Sep; 48(17):4783-9. PubMed ID: 2457430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo activity of alkylating bombesin receptor antagonists on small cell lung carcinoma.
    Ciomei M; Pastori W; Pastori A; de Castiglione R; Gozzini L; Corradi F
    Anticancer Res; 1993; 13(1):75-9. PubMed ID: 8386497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide.
    Carney DN; Cuttitta F; Moody TW; Minna JD
    Cancer Res; 1987 Feb; 47(3):821-5. PubMed ID: 3026617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Des-Met14]bombesin analogues function as small cell lung cancer bombesin receptor antagonists.
    Staley J; Coy D; Taylor JE; Kim S; Moody TW
    Peptides; 1991; 12(1):145-9. PubMed ID: 1646997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
    Lin JT; Coy DH; Mantey SA; Jensen RT
    J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.